Trial Profile
Clinical Trials Insight: 700029108
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2007
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Asthma; Grass pollen hypersensitivity
- Focus Adverse reactions; Therapeutic Use
- Sponsors Greer Laboratories
- 06 Dec 2007 New trial record.